iShares Neuroscience and HeaIBRNETF

13F holders, Q3 2025 (September 30)
4holders
1new positions
1sold out
$26.79avg. 13F price*

At the end of Q3 2025, 4 institutions reported holding iShares Neuroscience and Hea (IBRN) in their 13F filings, unchanged from Q2 2025. 1 opened new positions and 1 sold out. The largest holders were BlackRock, Inc. ($2.5M), Principal Securities, Inc. ($20K) and Cwm, LLC ($4K).

Company
iShares Neuroscience and Hea
CUSIP
46436E353
Latest filing quarter
Q2 2026

History

Number of 13F holders

012345 Q1 2024: 4Q1 2024Q2 2024: 4Q2 2024Q3 2024: 5Q3 2024Q4 2024: 2Q4 2024Q1 2025: 4Q1 2025Q2 2025: 4Q2 2025Q3 2025: 4Q3 2025Q4 2025: 3Q4 2025Q1 2026: 5Q1 2026Q2 2026: 5Q2 2026

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions1$1K
Exits1$2K

All 13F filers, Q2 2025 → Q3 2025: 56 shares bought and 85 shares sold, net −29 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 4 holders

BlackRock, Inc. 0.00% No change 94,000 $2.5M
Principal Securities, Inc. 0.00% No change 732 $20K
Cwm, LLC 0.00% No change 163 $4K
Harbour Investments, Inc. 0.00% New 56 $1K

"% of holder's portfolio" is IBRN's weight in each manager's 13F, not the share of iShares Neuroscience and Hea the manager owns.